EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 66
|
0.600 |
GeneticVariation
|
disease |
UNIPROT |
A Recurrent De Novo PACS2 Heterozygous Missense Variant Causes Neonatal-Onset Developmental Epileptic Encephalopathy, Facial Dysmorphism, and Cerebellar Dysgenesis.
|
29656858 |
2018 |
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 66
|
0.600 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Spatial Clustering of de Novo Missense Mutations Identifies Candidate Neurodevelopmental Disorder-Associated Genes.
|
28867141 |
2017 |
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 66
|
0.600 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
Intellectual Disability
|
0.410 |
GeneticVariation
|
group |
BEFREE |
Overview of the available clinical data allow to delineate the condition associated with PACS2 mutations as a variable trait, in which the key features are represented by moderate to severe ID, cerebellar dysgenesis and other CNS malformations, reduced growth, and facial dysmorphism.
|
30684285 |
2019 |
Intellectual Disability
|
0.410 |
Biomarker
|
group |
GENOMICS_ENGLAND |
Spatial Clustering of de Novo Missense Mutations Identifies Candidate Neurodevelopmental Disorder-Associated Genes.
|
28867141 |
2017 |
Intellectual Disability
|
0.410 |
Biomarker
|
group |
HPO |
|
|
|
Seizures
|
0.400 |
Biomarker
|
phenotype |
GENOMICS_ENGLAND |
Spatial Clustering of de Novo Missense Mutations Identifies Candidate Neurodevelopmental Disorder-Associated Genes.
|
28867141 |
2017 |
Global developmental delay
|
0.400 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Spatial Clustering of de Novo Missense Mutations Identifies Candidate Neurodevelopmental Disorder-Associated Genes.
|
28867141 |
2017 |
Seizures
|
0.400 |
Biomarker
|
phenotype |
HPO |
|
|
|
Global developmental delay
|
0.400 |
Biomarker
|
disease |
HPO |
|
|
|
Unspecified neurodevelopmental disorder
|
0.300 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
A Recurrent De Novo PACS2 Heterozygous Missense Variant Causes Neonatal-Onset Developmental Epileptic Encephalopathy, Facial Dysmorphism, and Cerebellar Dysgenesis.
|
30290155 |
2018 |
Abnormality of the cerebellum
|
0.300 |
Biomarker
|
group |
GENOMICS_ENGLAND |
Spatial Clustering of de Novo Missense Mutations Identifies Candidate Neurodevelopmental Disorder-Associated Genes.
|
28867141 |
2017 |
Epileptic encephalopathy
|
0.110 |
Biomarker
|
disease |
BEFREE |
A Recurrent De Novo PACS2 Heterozygous Missense Variant Causes Neonatal-Onset Developmental Epileptic Encephalopathy, Facial Dysmorphism, and Cerebellar Dysgenesis.
|
29656858 |
2018 |
Epileptic encephalopathy
|
0.110 |
Biomarker
|
disease |
HPO |
|
|
|
Astigmatism
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Cryptorchidism
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Hyperopia
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Orbital separation excessive
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Macrostomia
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Myopia
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Nystagmus
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Strabismus
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Delayed ability to walk
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Downward slant of palpebral fissure
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Synophrys
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|